Top Markets
Coin of the day
Upstream Bio, Inc. Upstream Bio, Inc.

Upstream Bio, Inc.

UPB
Rang in aandelen #15351
Upstream Bio, Inc. is a biotechnology company in the clinical development... Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Aandeelprijs
$6.56
Marktkapitalisatie
$357.23M
Verandering (1 dag)
-0.84%
Verandering (1 jaar)
-61.68%
Land
US
Handel Upstream Bio, Inc. (UPB)

Categorie

Koersgeschiedenis voor Upstream Bio, Inc. (UPB)
Hoogste slotkoers: $6.56 op 2026-09-01

Laagste slotkoers: $24.44 op 2024-10-01
Koersgeschiedenis van Upstream Bio, Inc. van 2024 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -45.19%
2025 43.52%
2024 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$548.15 40.18%
US
$1.03K 44.14%
NL
$153.87 538.73%
US
$121.37 -11.93%
AU
$748.60 4.92%
CH